首页> 外文期刊>Infection and immunity >Fusions of anthrax toxin lethal factor with shiga toxin and diphtheria toxin enzymatic domains are toxic to mammalian cells.
【24h】

Fusions of anthrax toxin lethal factor with shiga toxin and diphtheria toxin enzymatic domains are toxic to mammalian cells.

机译:炭疽毒素致死因子与志贺毒素和白喉毒素酶促结构域的融合体对哺乳动物细胞有毒。

获取原文
       

摘要

To investigate the ability of anthrax toxin lethal factor (LF) to translocate foreign proteins into the cytosol of eukaryotic cells and to characterize the structural requirements of this process, fusion proteins containing a portion of LF and the catalytic domains of either diphtheria toxin or Shiga toxin were constructed. Previous work showed that residues 1 to 254 of anthrax toxin lethal factor (LF1-254) are sufficient for binding to the protective antigen component of the toxin and that portions of Pseudomonas exotoxin A fused to LF1-254 are efficiently translocated to the cytosol of eukaryotic cells (N. Arora and S. H. Leppla, J. Biol. Chem. 268:3334-3341, 1993). In this study, it was found that fusion proteins containing the ADP-ribosylation domain of diphtheria toxin fused at either the amino end or the carboxyl end of LF1-254 are highly toxic to Chinese hamster ovary (CHO) cells, indicating that translocation does not strictly require that the amino terminus of LF be free. A fusion protein containing the ribosome-inactivating A1 subunit of Shiga toxin fused to the carboxyl terminus of LF1-254 was also highly toxic for CHO cells. All fusion proteins were toxic only when administered with the anthrax toxin protective antigen component. The data show that the combination of protective antigen and LF fusion proteins can efficiently import polypeptides from diverse bacterial sources to the cytosol of eukaryotic cells and that LF fusion proteins may have the passenger polypeptides fused at either the amino terminus or the carboxyl terminus of LF1-254. These LF fusion proteins could potentially be used as components of a therapeutic agent when the destruction of certain types of cells is desired (e.g., in treating cancer).
机译:为了研究炭疽毒素致死因子(LF)将外源蛋白转移到真核细胞胞质中的能力并表征该过程的结构要求,融合蛋白包含了一部分LF和白喉毒素或志贺毒素的催化域被建造。先前的工作表明,炭疽毒素致死因子(LF1-254)的残基1至254足以与毒素的保护性抗原成分结合,并且与LF1-254融合的假单胞菌外毒素A的一部分可以有效地转移到真核细胞质中细胞(N.Arora and SH Leppla,J.Biol.Chem.268:3334-3341,1993)。在这项研究中,发现包含融合在LF1-254的氨基端或羧基端的白喉毒素的ADP-核糖基化结构域的融合蛋白对中国仓鼠卵巢(CHO)细胞具有高毒性,这表明易位没有严格要求LF的氨基末端是自由的。融合志贺毒素的核糖体失活的A1亚基的融合蛋白与LF1-254的羧基末端融合,对CHO细胞也具有高毒性。所有融合蛋白仅在与炭疽毒素保护性抗原成分一起使用时才具有毒性。数据表明,保护性抗原和LF融合蛋白的结合可以有效地将多肽从多种细菌来源导入真核细胞的胞质溶胶中,并且LF融合蛋白可能在LF1的氨基末端或羧基末端融合了客体多肽。 254。当需要破坏某些类型的细胞时(例如在治疗癌症中),这些LF融合蛋白可以潜在地用作治疗剂的组分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号